Diabetes Mellitus Impact on Left Ventricular Assist Device Outcomes in Heart Failure Patients: National Inpatient Sample Study
North Florida Regional Medical Center
LVAD, NIS, diabetes, heart failure
Cardiovascular Diseases | Endocrine System Diseases | Internal Medicine | Nutritional and Metabolic Diseases
Aim: Diabetes mellitus (DM) is a recognized risk factor for heart failure (HF), increasing the likelihood of requiring left ventricular assist device (LVAD) therapy.
Objective: This retrospective cohort study aims to assess the impact of DM on LVAD patients, focusing on in-hospital mortality as the primary outcome.
Methods: Utilizing the National Inpatient Sample administrative database, data from 11,506 adult HF patients who underwent LVAD implantation were analyzed.
Results: Of the patients, 44.28% had diabetes. Adjusting for various factors, diabetic patients exhibited shorter hospital stays, lower admission costs and similar in-hospital mortality rates compared with non-diabetic patients.
Conclusion: These findings enhance our understanding of the risks and benefits of LVAD therapy in patients with refractory HF and DM.
Publisher or Conference
Obeidat O, Abdullahi AH, Ismail Z, et al. Diabetes mellitus impact on left ventricular assist device outcomes in heart failure patients: National Inpatient Sample study [published online ahead of print, 2023 Aug 14]. Future Cardiol. 2023;10.2217/fca-2023-0013. doi:10.2217/fca-2023-0013